simvastatin has been researched along with ADPKD in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Angioi, A; Bergstralh, EJ; Fervenza, FC; King, BF; Larson, TS; Sethi, S; Torres, VE; Zand, L | 1 |
Alisir, S; Ecder, T; Mercanoglu, F; Namli, S; Oflaz, H; Tufan, F; Turgut, F; Ucar, A | 1 |
Blauw, GJ; Kamper, AM; Souverijn, JH; van Dijk, MA; van Veen, S | 1 |
2 trial(s) available for simvastatin and ADPKD
Article | Year |
---|---|
Renal hemodynamic effects of the HMG-CoA reductase inhibitors in autosomal dominant polycystic kidney disease.
Topics: Female; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Magnetic Resonance Imaging; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Renal Circulation; Simvastatin | 2016 |
Effect of simvastatin on renal function in autosomal dominant polycystic kidney disease.
Topics: Acetylcholine; Adult; Cholesterol; Cross-Over Studies; Double-Blind Method; Female; Forearm; Glomerular Filtration Rate; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Kidney; Male; Polycystic Kidney, Autosomal Dominant; Renal Circulation; Simvastatin; Vasodilation; Vasodilator Agents | 2001 |
1 other study(ies) available for simvastatin and ADPKD
Article | Year |
---|---|
Improvement of endothelial dysfunction with simvastatin in patients with autosomal dominant polycystic kidney disease.
Topics: Adult; C-Reactive Protein; Cardiovascular Diseases; Endothelium, Vascular; Female; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-6; Male; Middle Aged; Polycystic Kidney, Autosomal Dominant; Simvastatin | 2007 |